Back

IL-6–mediated cardiac and vascular dysfunction in cancer cachexia

30 August 2026 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Cardio-immunology and inflammation Heart Failure ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speakers

Photo
Miss Ana Isabel Antunes Goncalves

Medical University of Vienna, Vienna (Austria)

Photo
Ms Qianling Ye

Wien (Austria)

5 More presentations in this session

Presentation thumbnail
Dual role of macrophages during the atrial cardiomyopathy
Mrs N. Suffee (Paris, FR)
Abstract Slides
Presentation thumbnail
LUBAC-mediated linear ubiquitination drives proinflammatory activation of macrophage in cardiac ischemia-reperfusion injury
Doctor Y. Yang (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Endotoxin-tolerance modulates the immune microenvironment of transplanted hearts through macrophage epigenetic and metabolic reprogramming
Doctor T. Wang (Hangzhou, CN)
Abstract Slides
Presentation thumbnail
Comparative transcriptomics reveals CXCL10/CXCR3 axis as a key driver of post-pneumonia heart failure
Mr D. Minassian (Birmingham, US)
Abstract Slides
Presentation thumbnail
Interferon-inducible macrophages drive fulminant myocarditis via a TLR3-IRF1-ACOD1 mitochondrial fission axis
Doctor H. Li (Wuhan, CN)
Abstract Slides

Access the full session

Session thumbnail
Cardio-immunology and inflammation

The Event

Event poster

ESC Congress 2026

30 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Interleukin-6 as a potential biomarker of cancer therapy-related cardiac dysfunction: A comparative analysis with myeloperoxidase and tumor necrosis factor-alpha.
21 June 2025
thumbnail
Congress Presentation
Changes in genes of both lipid and iron metabolism in epicardial adipose tissue are involved in cardiac cachexia
21 May 2023
thumbnail
Congress Presentation
Pressure overload-induced cardiac hypertrophy stimulates tumour growth in tumour prone apc-min mice
21 May 2022
thumbnail
Congress Presentation
Effect of intravitreal anti-vascular endothelial growth factor therapy on aortic stiffness and serum interleukin-6 levels in hypertensive patients with age-related macular degeneration
2 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources